Cargando…

Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity

BACKGROUND: Inflammatory bowel disease (IBD) can manifest both macroscopically and microscopically in the oral cavity; however, little is known about salivary changes in IBD. Therefore, this study aimed to assess salivary and circulatory inflammatory profiles in IBD and to compare their potential to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majster, Mirjam, Lira-Junior, Ronaldo, Höög, Charlotte M, Almer, Sven, Boström, Elisabeth A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500518/ https://www.ncbi.nlm.nih.gov/pubmed/32725166 http://dx.doi.org/10.1093/ibd/izaa190

Ejemplares similares

Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study
por: Zwicker, Stephanie, et al.
Publicado: (2017)

Interleukin 34: a new modulator of human and experimental inflammatory bowel disease
por: Zwicker, Stephanie, et al.
Publicado: (2015)

Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus
por: Ruacho, Guillermo, et al.
Publicado: (2022)

S100A12 Expression Is Modulated During Monocyte Differentiation and Reflects Periodontitis Severity
por: Lira-Junior, Ronaldo, et al.
Publicado: (2020)

Salivary microbial profiles in relation to age, periodontal, and systemic diseases
por: Lira-Junior, Ronaldo, et al.
Publicado: (2018)

Periodontitis is associated to increased systemic inflammation in postmyocardial infarction patients
por: Lira-Junior, Ronaldo, et al.
Publicado: (2021)

Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
por: Lira-Junior, Ronaldo, et al.
Publicado: (2016)

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders †
por: Haglund, Sofie, et al.
Publicado: (2023)

Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines
por: Boström, Elisabeth A., et al.
Publicado: (2015)

FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice
por: Bosma, Madeleen, et al.
Publicado: (2016)

Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease
por: Norén, Elisabeth, et al.
Publicado: (2017)

Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease – Novel Clues to Drug Targets and Disease Mechanisms?
por: Haglund, Sofie, et al.
Publicado: (2013)

Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility
por: Söderman, Jan, et al.
Publicado: (2015)

Nutritional Aspects in Inflammatory Bowel Diseases
por: Balestrieri, Paola, et al.
Publicado: (2020)

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury, Marc, et al.
Publicado: (2014)

Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients
por: Delmondes, Leda Maria, et al.
Publicado: (2015)

Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
por: Moon, Jin Soo
Publicado: (2019)

Clinical aspects and treatments for pediatric inflammatory bowel diseases
por: Moon, Jin Soo
Publicado: (2019)

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease
por: Dragasevic, Sanja, et al.
Publicado: (2022)

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017)

Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2020)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study
por: Oxelmark, Lena, et al.
Publicado: (2016)

Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease
por: Martinez-Fierro, Margarita L., et al.
Publicado: (2019)

Characterization of serum polyunsaturated fatty acid profile in patients with inflammatory bowel disease
por: Jiang, Jingjing, et al.
Publicado: (2023)

Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
por: Liu, Ruize, et al.
Publicado: (2023)

The relationship between sleep and salivary and serum inflammatory biomarkers in adolescents
por: Alqaderi, Hend, et al.
Publicado: (2023)

Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease
por: Zheng, Xiaowen, et al.
Publicado: (2017)

Colony stimulating factor-1 in saliva in relation to age, smoking, and oral and systemic diseases
por: Lira-Junior, Ronaldo, et al.
Publicado: (2017)

Adjunctive Antiseptic Irrigation of Periodontal Pockets: Effects on Microbial and Cytokine Profiles
por: Vitt, Anton, et al.
Publicado: (2020)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles
por: Xun, Zhe, et al.
Publicado: (2018)

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
por: Visuri, Isabella, et al.
Publicado: (2023)

Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance
por: Kim, Seung, et al.
Publicado: (2015)

The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects
por: Triantafillidis, John K., et al.
Publicado: (2015)

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_66o9h6t8hahp7sd9s07nv3u21h